While loss of a loved one or breakdown of a relationship is often linked to a "broken heart", not much is known why such emotional trauma could make someone physically ill. New research suggests that the body's own immune response could play a key role in the condition.
Symptoms of broken heart syndrome include shortness of breath and chest pain and as such it is often mistaken for a heart attack. However, unlike in a heart attack, patients do not suffer from a blockage of the arteries that supply the heart with blood.
The cause of broken heart syndrome is not clearly understood but often is a result of intense emotional or physical trauma, which is thought to induce a strong response that affects the heart tissue.
"We found that broken heart syndrome triggers a storm in the immune system which results in acute inflammation in the heart muscle. The heart muscle then spills inflammatory signals that are circulating throughout the body," said lead researcher Dana Dawson, Professor at University of Aberdeen in Scotland.
There is currently no treatment for broken heart syndrome, or Takotsubo cardiomyopathy.
The new study, published in the journal Circulation, suggests that drugs that target inflammation could offer hope of fixing broken hearts.
In the study, 55 patients with acute Takotsubo cardiomyopathy were recruited from five Scottish cardiac centres.
Using sophisticated MRI techniques, the researchers found that the inflammatory immune response in the hearts of those with broken heart syndrome was heightened compared to healthy volunteers.
This study also showed that signs of inflammation were still found five months later, albeit at a much lesser level.
"Takotsubo cardiomyopathy is a serious stress-induced condition which affects mainly women and can cause long-lasting damage and scarring to the heart muscle. Surprisingly, there are still large gaps in our knowledge of its underlying biology," said Professor Metin Avkiran, Associate Medical Director at the British Heart Foundation which funded the study.
"The discovery that it is accompanied by inflammation within the heart and in the rest of the body is an important step forward," Avkiran said.
"We now need further research to understand if inflammation causes Takotsubo cardiomyopathy and determine if drugs that target inflammation could be the key to fixing broken hearts," Avkiran said.
--IANS
pb/gb/sed
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
